Jason

The creation proclaims its Creator/Not of this world🎵/ Internal Medicine💊/ All about Kidneys🫘
#MedTwitter #NephTwitter #FOAMed #Nolefam

[Arkana Laboratories @arkanalabs]

What is your diagnosis?

#DiagnoseThis #nephtwitter #pathtwitter #renal #kidneypath

[S M Assad @assad_sm]

1/5🩸🔄 Worsening Acidosis and Anion gap climbing on CKRT?

Lactate’s clear, uraemia addressed, no toxins on board and the glucose is normal. Solute clearance looks fine, yet the acidosis keeps deepening.

Don’t stop there. Think ketones.
#NephTwitter
@isn_india @ISNkidneycare

[Brendon Neuen @brendonneuen]

VISIONARY trial press release: First APRIL inhibitor to demonstrate statistically significant eGFR stabilization with evidence of improvement versus placebo over two years in IgAN: https://t.co/GVRXtWGP63

[AJKD @AJKDonline]

Kidney Dysfunction in the Setting of Liver Failure: Core Curriculum 2024

https://t.co/SQxw6sF1U9

@SwethaKanduriMD @VelezNephHepato @OchsnerNephro

[VR.Krishnakumar @KKNephBytes]

Transplant-Free Survival in Patients with Acute Liver Failure Treated with Extracorporeal Therapies

https://t.co/Yt7YvatYk6
@vjha126 @drvivekkute @arvindcanchi @isn_india @DrAkshayaJ @priti899

[Prateekaaryan 𝕏 @AaryanPrateekX]

The Chetan Bhagat who sold fake love stories like Half Girlfriend to the youth and pushed the idea that you have to be a beta, cuck, simp chxutpaglu to get a girl and her love is now defending how Siya was oppressed and couldn’t say “no.”

At 16, she was partying, clubbing, and sleeping around, and now, as an adult with voting rights, we’re supposed to believe she couldn’t say no.

Accountability is women’s kryptonite, and simps like Chetan are the shield who come to defend them and deny their accountability.

[Matthew Sparks, MD @Nephro_Sparks]

Avacopan retracted

https://t.co/YZsJ5O7ox3

[AJKD @AJKDonline]

In A Few Words essay by Adam Krieger:

"Dialysis keeps people alive, but it also consumes them. We cannot dialyze a broken system, and we must not allow that system to dialyze away our vigilance."

What We Cannot Dialyze https://t.co/nPZx5V9J8u (FREE)

@TulaneMedicine

[Nephrology Journal Club @NephJC]

🚨🚨Had our kick-off today...new #NephJC interns are on the loose in July.
Let's give them a hand 👏
Keep an eye out for new blog and VA creators 👀
#NephTwitter #MedTwitter
@hswapnil @kidney_boy @CristinaDeReins @dra_miliflores @DrAkshayaJ @brian_rifkin

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Fabry Disease: Current Perspectives on Diagnosis and Management Strategies ca. 2026 from @akdhjournal @SaynaNorouzi @DrAnjayRastogi @ZohrehGh7
#Nephpearls

👉🏼 https://t.co/LPWy18PdR2

[ERA - European Renal Association @ERAkidney]

Primary & secondary glomerulonephritis, vasculitis, autoimmune diseases
Anti-GBM disease
from Prof Mårten Segelmark

1⃣/1⃣4⃣

#eraedta21

[Indian Society of Nephrology @isn_india]

🔬PLA2R. NELL1. Rituximab. Ponticelli.

If these keywords spark your interest, tune in 🎙️to our latest Kidney Konversations podcast with @raja_1980 on Membranous Nephropathy!

Hosts: @arvindcanchi @DrAkshayaJ
Spotify: https://t.co/Ucc3GxrP2w

Apple Music: https://t.co/BPoWYwk4Pl

[RECAT👩🏽‍⚕️🏥👨🏽‍⚕️🇲🇽🫀 @LeslieMegom]

💧Diálisis peritoneal: alternativa limitada (útero, riesgo infeccioso)
⚙️ Prescripción sugerida (HD)⚠️Sin comprometer la perfusión uteroplacentaria, minimizando el riesgo de progresión a ERC.
💧Sesiones más frecuentes y más cortas
💧Ultrafiltración lenta y conservadora
💧Evitar grandes cambios osmolares
💧Temperatura ligeramente baja (36 °C)🌡
🫃📌 Recomendación ▪️Duración,2–3 h ▪️Frecuencia: Diaria o días alternos ▪️UF≤ 500–1000 ml/sesión. ▪️Flujo sanguíneo: Moderado ▪️Sodio: Evitar hiponatremia rápida
⚠️Riesgos materno-fetales
🫃Maternos
▪️Hipotensión → hipoperfusión renal residual
▪️Empeoramiento de AKI → ERC
▪️Acceso vascular (infección, trombosis) 👶Fetales
▪️↓ perfusión uteroplacentaria
▪️Sufrimiento fetal
▪️Parto pretérmino
▪️Restricción del crecimiento. 👉 HD debe ser coordinada con obstetricia y, cuando es viable, con monitoreo fetal.
🫃PR-AKI, hemodiálisis y progresión a ERC
▪️La evidencia muestra que:
▪️Hasta 30–35% de mujeres con PR-AKI que requieren HD. 👉 evolucionan a ERC
▪️30% pueden quedar dependientes de diálisis
No recuperación renal > 6 semanas📌 La necesidad de HD en PR-AKI es un marcador de daño renal estructural, no solo funcional.
📌🎯Perlas clínicas (alto valor en UCI / obstetricia crítica)
▪️No retrasar diálisis “por estar embarazada”🫃
→ Retrasar HD aumenta mortalidad materna y fetal.
▪️Evitar ⚠️
→ La sobrecarga hídrica es la causa más frecuente de inicio de HD.💧
⚠️Si no mejora tras el parto, piensa en microangiopatía trombótica./Síndrome urémico hemolítico atípico.
→ No todo es HELLP.‼️‼️
⚠️EVITAR!!
→ Hipotensión intradialítica = sufrimiento fetal.
→ AKI en embarazo ≠ evento transitorio.
👇🏽👇🏽👇🏽 https://t.co/UbBuisSNYt
📜https://t.co/hFJX5VZFEi

[S M Assad @assad_sm]

🔈@OffCMCVellore invites you to RCC 2026
🧑🏻‍⚕️Designed for PGs seeking experience in an exam setting with real patients & experienced examiners, as well as nephrologists looking to deepen their knowledge of AKI

Join us on 24-25th 2026 🗓️at CMC Vellore📍

@jjeapen @manishmedicine1

[Akshaya Jayachandran 🇮🇳 @DrAkshayaJ]

🚨Are you a postgraduate eager to experience a nephrology practical exam in real time with live cases and expert examiners? 🩺

Or a nephrologist looking for a deep dive into AKI? ✨

Join us at @CMCNephrology’s RCC ‘26!

🗓️24-25th July 2026
📍Vellore

@jjeapen @manishmedicine1

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Among immune compromised patients with bacteremia included in BALANCE, this post hoc analysis did not find a statistically significant difference in 90-day mortality between those receiving 7 vs 14 days of antibiotic therapy and the confidence intervals remained below the trial’s non-inferiority margin. #idxposts

[ASN Publications @asnpublications]

Is the use of nondialyzable vs dialyzable beta-blockers associated with different cardiovascular outcomes among patients initiating hemodialysis? Find out in #ASNJASN https://t.co/WMlBvtZVTi

[Jessica Meir @Astro_Jessica]

There is a lot going on right now on the @Space_Station, but fortunately we are all safe and witnessed a spectacular southern aurora show yesterday thanks to a recent solar event.

[Jason @LovelinJason]

Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy | New England Journal of Medicine https://t.co/AWETbAGWhm

[Arunkumar @Arunkr_Dr]

@ERAkidney @VladoPerkovic @HeerspinkHiddo @brendonneuen 🔥 INFINITY pooled analysis (FIDELIODKD + FIGARODKD + FINDCKD)
Finerenone: ✅ Kidney outcome HR 0.76 ✅ HF hospitalization HR 0.78 ✅ CV death HR 0.82 ✅ All-cause mortality HR 0.88

One of the strongest cardiorenal datasets yet for CKD across diabetic + non-DM populations #ERA26